MSH|^~\&#|STARLIMS.CDC.Stag^2.16.840.1.114222.4.3.3.2.1.2^ISO|CDC Atlanta^11D0668319^CLIA|CLIMS.NY.Stag^2.16.840.1.114222.4.3.3.2.17.2^ISO|NYSDOH^2.16.840.1.114222.4.1.3673^ISO|20230405133610-0400||ORU^R01^ORU_R01|24095_3015822725_04204575_5120|T|2.5.1|||NE|NE|USA|8859/1|||PHLabReport-NoAck^PHIN^2.16.840.1.113883.9.11^ISO
SFT|CDC^^^^^CDC&2.16.840.1.114222.4&ISO^XX^^^CDC CLIA|ELIMS V11|STARLIMS|Binary ID unknown
PID|1||PID03423907^^^STARLIMS.CDC.Stag&2.16.840.1.114222.4.3.3.2.1.2&ISO^PI||Yeo-jeong^Cho^^^^^L||20000405|F|||^^^^^USA^H
NTE|1|L|Case Summary Notes|RE^Remark^HL70364
NTE|2|L|Case Comments|RE^Remark^HL70364
NTE|3|L|CDC Specimen ID: 3015822725, Intermediate Submitter: NYSDOH Wadsworth Center, Virology Lab, Submitter ID:SPHL-000025, Address: Axelrod Institute 120 New Scotland Avenue Albany, New York 12208 United States, Email: virology@health.ny.gov, Submitter Case ID: , Submitter Patient ID: 111, Submitter Alt Patient ID: 222, Submitter Specimen ID: 333, Submitter Alt Specimen ID:444|RE^Remark^HL70364
NTE|4|L|Additional IDs for CDC Specimen ID 3015822725 are Local ID No.: 1234, Case Number: 5678|RE^Remark^HL70364
NTE|5|L|04/05/2023: Final Case Report Generated > Report Request ID(s): 135790,  04/05/2023: Case Metadata changed > Asian changed from 'Y' to 'N',  04/05/2023: CSID: 3015822725 > Trypanosoma cruzi Multi-target Real-Time PCR Result Changed (ZZYGKOYQ): Trypanosoma cruzi Multi-target Real-Time PCR - from '1st Positive' to 'Negative',  04/05/2023: CSID: 3015822725 > Trypanosoma cruzi Multi-target Real-Time PCR > Trypanosoma cruzi Multi-target Real-Time PCR > Result Comment Added > The submitted sample is negative for <i>Trypanosoma cruzi</i> DNA. Sensitivity of this test is 100% for clinical samples from patients in the acute phase of Chagas disease, when compared to microscopic examination.  Sensitivity of detection in chronically infected (sero-positive) patients with compromised immune system is 29% (64 positives out of 223 specimens).  This test has not been evaluated for use in immunocompetent patients with chronic Chagas disease, in which case serological tests are more appropriate. This test has 96% specificity and may cross-react with other <i>Trypanosoma</i> species and <i>Leishmania</i>.,  04/05/2023: Corrected Case Report Generated > Report Request ID(s): 135792,  04/05/2023: Case Metadata changed > Asian changed from 'Y' to 'N'|RE^Remark^HL70364
ORC|RE|CDC_3015822725^CDC^1.111.122311.222.44.2.3.3^ISO|3015822725_04204575^STARLIMS.CDC.Stag^2.16.840.1.114222.4.3.3.2.1.2^ISO|||||||||SPHL-000025^NYSDOH Wadsworth Center, Virology Lab^^^^^^^STARLIMS.CDC.Stag&2.16.840.1.114222.4.3.3.2.1.2&ISO^^^^XX||^WPN^PH^^1^518^4744177^^^^^+1 518 474 4177|||||||NYSDOH Wadsworth Center, Virology Lab^D^^^^STARLIMS.CDC.Stag&2.16.840.1.114222.4.3.3.2.1.2&ISO^XX^^^SPHL-000025|Axelrod Institute^120 New Scotland Avenue^Albany^NY^12208^USA^M|^WPN^PH^^1^518^4744177^^^^^+1 518 474 4177|Axelrod Institute^120 New Scotland Avenue^Albany^NY^12208^USA^M
OBR|1|CDC_3015822725^CDC^1.111.122311.222.44.2.3.3^ISO|3015822725_04204575^STARLIMS.CDC.Stag^2.16.840.1.114222.4.3.3.2.1.2^ISO|68991-9^Epidemiologically Important Information^LN|||20230227|||||||||SPHL-000025^NYSDOH Wadsworth Center, Virology Lab^^^^^^^STARLIMS.CDC.Stag&2.16.840.1.114222.4.3.3.2.1.2&ISO^^^^XX|^WPN^PH^^1^518^4744177^^^^^+1 518 474 4177|||||20230405133600-0400|||F
OBX|1|DT|11368-8^Illness or injury onset date and time^LN||20230201||||||F|||20230227|11D0668319||||20230227||||CDC Atlanta Lab^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^11D0668319|1600 Cliffton Road^^Atlanta^GA^30329^USA^B
OBX|2|SN|21612-7^Reported Patient Age^LN||=^23|a^Year^UCUM|||||F|||20230227|11D0668319||||20230227||||CDC Atlanta Lab^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^11D0668319|1600 Cliffton Road^^Atlanta^GA^30329^USA^B
SPM|1|^3015822725&STARLIMS.CDC.Stag&2.16.840.1.114222.4.3.3.2.1.2&ISO||119297000^Blood^SCT^^^^09012017^^Blood|||||||||||||20230227|20230405
OBR|2|CDC_3015822725^CDC^1.111.122311.222.44.2.3.3^ISO|52_3015822725_04204575_813^STARLIMS.CDC.Stag^2.16.840.1.114222.4.3.3.2.1.2^ISO|PLT1088^T cruzi DNA XXX Ql NAA+probe^PLT^813^Trypanosoma cruzi Multi-target Real-Time PCR^L|||20230227|||||||||SPHL-000025^NYSDOH Wadsworth Center, Virology Lab^^^^^^^STARLIMS.CDC.Stag&2.16.840.1.114222.4.3.3.2.1.2&ISO^^^^XX|^WPN^PH^^1^518^4744177^^^^^+1 518 474 4177|||||20230405120400-0400|||C
NTE|1|L|If this report includes a molecular diagnostic result, please note: the performance characteristics of the molecular diagnostic test(s) on this report were determined by validations performed at the Division of Parasitic Diseases and Malaria (DPDM) at the Centers for Disease Control |RE^Remark^HL70364
NTE|2|L|Case Comments|RE^Remark^HL70364
OBX|1|CWE|PLT1088^T cruzi DNA XXX Ql NAA+probe^PLT|ZZYGKOYQ-1|260385009^Negative (qualifier value)^SCT^^^^09012018^^Negative||||||C|||20230227|11D0668319^Centers for Disease Control and Prevention^CLIA||||20230405120400+0000||||Centers for Disease Control and Prevention^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^11D0668319|1600 Cliffton Rd^^Atlanta^GA^30329^USA^B
NTE|1|L|The submitted sample is negative for <i>Trypanosoma cruzi</i> DNA. Sensitivity of this test is 100% for clinical samples from patients in the acute phase of Chagas disease, when compared to microscopic examination.  Sensitivity of detection in chronically infected (sero-positive) patients with compromised immune system is 29% (64 positives out of 223 specimens).  This test has not been evaluated for use in immunocompetent patients with chronic Chagas disease, in which case serological tests are more appropriate. This test has 96% specificity and may cross-react with other <i>Trypanosoma</i> species and <i>Leishmania</i>.|RE^Remark^HL70364
SPM|1|^3015822725&STARLIMS.CDC.Stag&2.16.840.1.114222.4.3.3.2.1.2&ISO||119297000^Blood^SCT^^^^09012017^^Blood|||||||||||||20230227|20230405
